These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36422266)

  • 1. Investigation of Genetic Variants Associated with Tryptophan Metabolite Levels via Serotonin and Kynurenine Pathways in Patients with Bipolar Disorder.
    Pisanu C; Squassina A; Paribello P; Dall'Acqua S; Sut S; Nasini S; Bertazzo A; Congiu D; Meloni A; Garzilli M; Guiso B; Suprani F; Pulcinelli V; Iaselli MN; Pinna I; Somaini G; Arru L; Corrias C; Pinna F; Carpiniello B; Comai S; Manchia M
    Metabolites; 2022 Nov; 12(11):. PubMed ID: 36422266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the tryptophan-kynurenine pathway and painful physical symptoms in patients with major depressive disorder.
    Yun Y; Zhang Q; Zhao W; Ma T; Fan H; Bai L; Ma B; Qi S; Wang Z; An H; Yang F
    J Psychosom Res; 2022 Dec; 163():111069. PubMed ID: 36335711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum neuroactive metabolites of the tryptophan pathway in patients with acute phase of affective disorders.
    Li Y; Wang L; Huang J; Zhang P; Zhou Y; Tong J; Chen W; Gou M; Tian B; Li W; Luo X; Tian L; Hong LE; Li CR; Tan Y
    Front Psychiatry; 2024; 15():1357293. PubMed ID: 38680780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between circulating interferon and kynurenine/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLE.
    Anderson EW; Jin Y; Shih A; Arazi A; Goodwin S; Roeser J; Furie RA; Aranow C; Volpe B; Diamond B; Mackay M
    Lupus Sci Med; 2022 Nov; 9(1):. PubMed ID: 36384965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grey and white matter structure associates with the activation of the tryptophan to kynurenine pathway in bipolar disorder.
    Poletti S; Melloni E; Aggio V; Colombo C; Valtorta F; Benedetti F; Comai S
    J Affect Disord; 2019 Dec; 259():404-412. PubMed ID: 31610997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in plasma kynurenine pathway metabolites in children and adolescents with bipolar disorder and unaffected offspring of bipolar parents: A preliminary study.
    Benevenuto D; Saxena K; Fries GR; Valvassori SS; Kahlon R; Saxena J; Kurian S; Zeni CP; Kazimi IF; Scaini G; Soares JC; Quevedo J
    Bipolar Disord; 2021 Nov; 23(7):689-696. PubMed ID: 33098737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinolinic acid, a kynurenine/tryptophan pathway metabolite, associates with impaired cognitive test performance in systemic lupus erythematosus.
    Anderson EW; Fishbein J; Hong J; Roeser J; Furie RA; Aranow C; Volpe BT; Diamond B; Mackay M
    Lupus Sci Med; 2021 Oct; 8(1):. PubMed ID: 34686589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of periodontal inflammation on tryptophan-kynurenine metabolism: a cross-sectional study.
    Kurgan Ş; Önder C; Balcı N; Akdoğan N; Altıngöz SM; Serdar MA; Günhan M
    Clin Oral Investig; 2022 Sep; 26(9):5721-5732. PubMed ID: 35588020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous detection of stable isotope-labeled and unlabeled L-tryptophan and of its main metabolites, L-kynurenine, serotonin and quinolinic acid, by gas chromatography/negative ion chemical ionization mass spectrometry.
    Sano M; Ferchaud-Roucher V; Nael C; Aguesse A; Poupeau G; Castellano B; Darmaun D
    J Mass Spectrom; 2014 Feb; 49(2):128-35. PubMed ID: 24677305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum levels of kynurenine pathway metabolites in patients with Behçet disease.
    Eryavuz Onmaz D; Tezcan D; Abusoglu S; Sivrikaya A; Kuzu M; Yerlikaya FH; Yilmaz S; Unlu A
    Amino Acids; 2022 Jun; 54(6):877-887. PubMed ID: 35604497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective association of cytokine levels and kynurenine/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression.
    Comai S; Melloni E; Lorenzi C; Bollettini I; Vai B; Zanardi R; Colombo C; Valtorta F; Benedetti F; Poletti S
    Eur Neuropsychopharmacol; 2022 Feb; 55():96-109. PubMed ID: 34847455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a systematic review and meta-analysis of cerebrospinal fluid studies.
    Inam ME; Fernandes BS; Salagre E; Grande I; Vieta E; Quevedo J; Zhao Z
    Braz J Psychiatry; 2023 May; 45(4):343-55. PubMed ID: 37127280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity.
    Vidal R; García-Marchena N; O'Shea E; Requena-Ocaña N; Flores-López M; Araos P; Serrano A; Suárez J; Rubio G; Rodríguez de Fonseca F; Colado MI; Pavón FJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Aug; 102():109958. PubMed ID: 32360814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder.
    Mukherjee D; Krishnamurthy VB; Millett CE; Reider A; Can A; Groer M; Fuchs D; Postolache TT; Saunders EFH
    Bipolar Disord; 2018 Feb; 20(1):27-34. PubMed ID: 28833866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tryptophan via serotonin/kynurenine pathways abnormalities in a large cohort of aggressive inmates: markers for aggression.
    Comai S; Bertazzo A; Vachon J; Daigle M; Toupin J; Côté G; Turecki G; Gobbi G
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():8-16. PubMed ID: 27117820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
    Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
    Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kynurenine pathway in Coronavirus disease (COVID-19): Potential role in prognosis.
    Cihan M; Doğan Ö; Ceran Serdar C; Altunçekiç Yıldırım A; Kurt C; Serdar MA
    J Clin Lab Anal; 2022 Mar; 36(3):e24257. PubMed ID: 35092710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periconceptional Non-medical Maternal Determinants Influence the Tryptophan Metabolism: The Rotterdam Periconceptional Cohort (Predict Study).
    van Zundert SK; van Rossem L; Mirzaian M; Griffioen PH; Willemsen SP; van Schaik RH; Steegers-Theunissen RP
    Int J Tryptophan Res; 2024; 17():11786469241257816. PubMed ID: 38873365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced peripheral availability of tryptophan and increased activation of the kynurenine pathway and cortisol correlate with major depression and suicide.
    Messaoud A; Mensi R; Douki W; Neffati F; Najjar MF; Gobbi G; Valtorta F; Gaha L; Comai S
    World J Biol Psychiatry; 2019 Nov; 20(9):703-711. PubMed ID: 29683396
    [No Abstract]   [Full Text] [Related]  

  • 20. Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression.
    Haroon E; Welle JR; Woolwine BJ; Goldsmith DR; Baer W; Patel T; Felger JC; Miller AH
    Neuropsychopharmacology; 2020 May; 45(6):998-1007. PubMed ID: 31940661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.